/C O R R E C T I O N -- Color Health/
Programs were designed in collaboration with the American Cancer Society
CHICAGO, June 2, 2025 /PRNewswire/ -- Yesterday at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting, Color Health presented new findings on the effectiveness of two nation-wide, virtual-first screening programs for colorectal and lung cancer. These programs were designed to expand access to cancer screening and were developed in collaboration with the American Cancer Society.
Aligned with the conference theme of "Driving Knowledge to Action: Building a Better Future," Color's Virtual Cancer Clinic is dedicated to delivering center of excellence cancer care to all patients, from screening to survivorship care. The research presented today at ASCO reflects a commitment to access and rigorous evaluation. Titled "Improving Access to Cancer Screening Through National Telehealth-Based Lung and Colorectal Cancer Screening Programs," the research highlights preliminary results from two initiatives aimed at reducing inequities in early cancer detection using a virtual-first model.
"Despite strong evidence supporting the efficacy of cancer screening, many patients - particularly those in healthcare deserts - face logistical, financial, and systemic barriers," said senior author William L. Dahut, MD, Chief Scientific Officer for the American Cancer Society. "The programs demonstrate that telehealth can be a powerful tool to deliver equitable, scalable cancer screening."
Program Highlights
The Color free cancer screening programs based on ACS screening guidelines and analyzed by Color utilize a centralized digital interface for cancer risk assessments, patient education, home-based testing, and appointment scheduling. Color, through its physician-led team implementing the program, personalized recommendations and managed follow-up on results.1
Colorectal Cancer (CRC) Screening Program: Launched in June 2024, Color drives CRC testing through a closed-loop virtual clinical program. At-home fecal immunochemical tests (FIT) are distributed to eligible adults (ages 45–75) via community partners such as federally qualified health centers and libraries.
Lung Cancer Screening Program: Initiated in November 2023, Color evaluates eligibility of individuals seeking lung cancer screening, enables low-dose CT scan scheduling, and ensures appropriate clinical follow-up of results through its virtual platform.
Research Focus
Determine patient-initiated interest and final eligibility for cancer screening
Evaluate success of community partnerships and virtual care navigation to enable rapid, accessible cancer screening
Determine outcomes of closed-loop, physician-led virtual cancer screening clinical management
"This work demonstrates how we can reimagine cancer care as a service that meets people where they are - at home and in their communities," said co-author Rebecca Miksad, MD, MPH, Chief Medical Officer at Color Health. "By integrating virtual care with personalized support, we can bridge persistent gaps in access and bring evidence-based preventive care to those who need it most."
"We believe we've shown what's possible when technology, public health, and community infrastructure come together to remove long-standing barriers to cancer prevention," said Miksad. "We are proud to work with the ACS to support innovative models that help ensure equitable access to life-saving cancer care delivery."
The data demonstrate that telehealth-driven, community-based models can meaningfully deliver access to cancer screening. By reducing logistical barriers and offering personalized, virtual support and medical care, these programs represent a scalable strategy to close screening gaps nationwide.
Poster Details
Title: Improving access to cancer screening through national telehealth-based lung and colorectal cancer screening programs
Abstract: 1549
Poster Board Number: 315
About Color Health
Color Health is changing the way patients access cancer care through a first-of-its-kind, vertically integrated, and fully owned Virtual Cancer Clinic. Powered by a 50-state oncologist-led team of clinical experts, Color provides proactive, evidence-based care that is accessible to anyone, anytime, and at every step of the cancer journey. We partner with employers, health plans, unions, and government agencies to improve accessibility of early interventions, timely diagnosis, oncology care management, and survivorship care. Connect with Color on Twitter, LinkedIn, Facebook and www.color.com.
1 ACS does not provide clinical care. ACS does not endorse any product, service, or providers.
Media ContactAndy Killandy.kill@color.com
Lily Peskincolor@12080group.com
View original content:https://www.prnewswire.com/news-releases/color-health-presents-findings-on-national-telehealth-based-cancer-screening-programs-at-asco-2025-302470671.html
SOURCE Color Health
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
22 minutes ago
- Newsweek
Mom Gives Birth to Healthy Baby Boy, Then One Test Changes Their Lives
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A woman who had a healthy pregnancy and smooth labor was shocked to discover that something was wrong after giving birth to her baby boy, Brooks. Brooks failed the initial hearing screening the first time shortly after birth. It was then re-done, and he failed two more times. He was invited back for a fourth time, and again, he failed. His mom, Morgan Deakin, 23, initially thought it was due to mucus being in his ears - a common issue for newborns. But, at just three weeks old, Deakin and her partner Leon, 25, were told their baby is completely deaf. "It changed our lives entirely, and shaped the way we see life," the Scotland-based mom told Newsweek. "At first, it was overwhelming — there were so many emotions, from shock and grief to worry about what his future might look like." Deakin holding her son, Brookes. A close up of the now-17-weeks old baby. Deakin holding her son, Brookes. A close up of the now-17-weeks old baby. TikTok/@morgandeakinx According to the Scottish Government, around 1.1 babies per 1,000 births are born with permanent bilateral deafness. In comparison, the CDC states that about 2 to 3 out of every 1,000 children in the United States are born with a detectable level of hearing loss in one or both ears. Deakin regularly goes viral on TikTok, sharing her son's story (@morgandeakinx). In one clip detailing the diagnosis, she explained that they cried for days, then on the third day, their mindset adjusted. "It sunk in that crying isn't going to do anything. We've been in a great mindset since then," she said. She told Newsweek: "It's not the journey we imagined, but it's one we're embracing — and Brooks is showing us every day just how strong, resilient, and full of potential he is. "We also have changed as individuals, I would say. We are kinder in our hearts and see the world in a different light — a beautiful, kind, caring, and diverse little world which we were slightly ignorant to before. It has shaped us into better parents." Deakin feeding Brooks after his hearing aid fitting. A close up of the ten-week-old baby with the device in his ear. Deakin feeding Brooks after his hearing aid fitting. A close up of the ten-week-old baby with the device in his ear. TikTok/@morgandeakinx At ten weeks old, Brooks received hearing aids for the first time, which has left the internet in tears. She told Newsweek: "The hearing aids haven't helped at all at the moment; their purpose is to stimulate the auditory nerves to keep the auditory pathways open. "Although Brooks has not been able to be exposed to sound just yet, it is allowing him to get used to wearing them. Hopefully, further down the line, he can get cochlear implants and wear these as he's used to them." So far, the video has over 76,000 views and more than 5,300 likes. "Awww little angel. makes you realize the things we take for granted," said one commenter. Another wrote: "I am almost fully deaf but I can speak & communicate so well due to learning to lip read. He will pick up SO much by just watching you. You're amazing parents to your lovely boy." Morgan told Newsweek: "We've quickly found ourselves thrown into a whole new world of audiology appointments, learning about communication options like BSL and auditory verbal therapy, and figuring out how to advocate for him. But as time has gone on, it's also opened a different perspective. "We've met incredible professionals and other families, started learning more about deaf culture, and realized how many ways there are for Brooks to thrive and communicate."
2 hours ago
Profits drop at Warren Buffett's Berkshire Hathaway as it writes down its Kraft Heinz investment
OMAHA, Neb. -- OMAHA, Neb. (AP) — Warren Buffett's company reported less than half as much profit in the second quarter as it took a $3.76 billion writedown on the value of its stake in Kraft Heinz, as that iconic food producer considers largely undoing the merger that Berkshire Hathaway helped bankroll. Berkshire said it earned $12.37 billion, or $8,601 per Class A share, during the quarter. That's down from $30.248 billion, or $21,122 per Class A share, a year ago, because it recorded a much smaller paper investment gain this year. Berkshire's earnings can swing wildly from quarter to quarter because it has to record the current value of its massive investment portfolio even though it doesn't sell most of the stocks. That's why Buffett has long recommended that investors pay more attention to Berkshire's operating earnings, which exclude those investment gains. Although last year Berkshire did surprise shareholders by selling off a huge chunk of its Apple stake which inflated the investment gains then. By that measure, Berkshire's operating earnings were only down slightly at $11.16 billion, or $7,759.58 per Class A share. That compares with $11.598 billion, or $8,072.16 per Class A share, a year ago. Most of Berkshire's myriad assortment of companies — major insurers like Geico, BNSF railroad, a group of utilities and a collection of manufacturing and retail businesses — generally performed well despite the uncertainty about the economy and President Donald Trump's tariffs. The four analysts surveyed by FactSet Research expected Berkshire to report earnings per Class A share of $7,508.10, so the Omaha, Nebraska-based conglomerate's results were ahead of that. Berkshire owns more than 27% of Kraft Heinz' stock and, for years, it had representatives on the company's board. Buffett has said previously that he believes the company's iconic brands will do well over time, but in hindsight, he overpaid for the investment and underestimated the challenges branded foods face from retailers and the growth of private label products. This spring, Berkshire's representatives resigned from the Kraft Heinz board shortly before the company announced it is exploring strategic options that may include spinning off a large part of its portfolio of brands. Over the years since Berkshire helped Kraft buy Heinz in 2015, the company has been hurt by changing consumer tastes and a shift toward healthier options than Kraft's core collection of processed foods. Buffett's is still sitting on a massive pile of $344.1 billion in cash, although the company's reserves dipped slightly from the $347.7 billion cash it was holding at the end of the first quarter. Buffett told shareholders in May he just isn't finding any attractive deals for companies he understands. Buffett surprised shareholders at the annual meeting when he announced that he plans to give up the CEO title at the end of the year and hand over operations to Vice Chairman Greg Abel, but Buffett will remain Chairman. Berkshire shareholders might be disappointed that the company didn't repurchase any of its shares this quarter, even though the price has fallen more than 12% since just before Buffett announced his retirement. Many investors are watching Berkshire's BNSF closely after rival Union Pacific announced a plan to buy Norfolk Southern earlier this week to create the nation's first transcontinental railroad. The speculation is that BNSF needs to pursue a merger with eastern rail CSX to be able to compete. But CFRA Research analyst Cathy Seifert said it isn't Buffett's style to jump into a deal just because the market thinks he should. Over the decades, he has built Berkshire by finding strong companies selling for less than they are worth. CSX is trading near its 52-week high at $35.01 amid all the deal speculation. 'He wants to do it because he found an undervalued franchise -- not because the market says you need to do a deal,' Seifert said. 'I think one of the reasons why that cash hasn't been deployed is that valuations run through the Berkshire M-and-A model tend to be too rich. But if there's a logical case to be made they'll accept it.' And BNSF appears to be doing fine right now on its own. The railroad recorded a 19% jump in its operating profit this quarter at $1.47 billion as it cut costs and delivered about 1% more shipments.
Yahoo
2 hours ago
- Yahoo
The Saturday Spread: How to Use Descriptive Math to Play the Hand, Not the Dealer
Suppose that you're the manager of an MLB team and it's the bottom of the ninth of the World Series. You're down to your last out. Do you go with the player who has a great career batting average but can't perform well under pressure or elect the guy who had a relatively average season but consistently comes through in the clutch? If you're into baseball or just sports in general, the answer is obvious: you go with the competitor that contextually gives you the best chance to win. Ultimately, your job is to take home championships, not dabble with math exercises. More News from Barchart How to Buy KO for a 2% Discount, or Achieve a 17% Annual Return Coinbase Shows Huge Unusual Options Volume After Lower Results Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! However, what seems so obvious isn't that way in the financial sector. Practically every western approach — from Black-Scholes-Merton-based models to the efficient market hypothesis — utilizes prescriptive financial modeling. Essentially, these methodologies dictate what should be, which theoretically sounds enticing. However, my contention is that this prescription is flawed. In contrast, I prefer a Markovian approach, which models behavior based on a descriptive framework. Such methodologies demonstrate what has been, not what should be. As such, we don't need complicated formulas rooted in stochastic calculus and other difficult concepts. A key reason why I'm not a fan of prescriptive models like Black-Scholes (aside from its inapplicability with American options) is that the underlying probabilities are based on the entire distribution of the dataset. That's like trying to predict hurricanes based on the last ten years' worth of weather reports. Instead, to accomplish this, you would focus on the immediate conditions that cause hurricanes to be more likely. With that said, below are three stocks that are potentially flashing buy signals based on a descriptive framework. Kroger (KR) Quantitatively, Kroger (KR) makes for an intriguing idea for bullish speculators. In the past 10 weeks, the market has essentially voted to buy KR stock four times and sell six times. Throughout this period, KR enjoyed an upward bias. For brevity, we can abbreviate the sequence as 4-6-U. At first glance, it may seem silly to compress the price magnitude of KR stock into a simple binary code. But what we have accomplished here is to define KR's price discovery process as a behavioral state. Through the study of past analogs, we can determine how the market responds to the 4-6-U sequence relative to the baseline. It's just like card counting in blackjack. If the deck favors us, we bet big. If it doesn't, we bet small (or in this case, not at all). On any given week, the chance that a long position in KR stock will rise is only 51.74%. It's an upward bias but a very modest one. However, this statistic stems from the derivative probability of upside across the entire distribution of the dataset. But our contention is that because the deck is flashing a 4-6-U sequence, the odds of upside are actually 72.73%. Barchart Premier members gain full access to the platform's options pricing tools, which can be incredibly powerful when integrated with a Markovian approach. Here, we can identify that the 72/73 bull call spread expiring Aug. 29 may be the least expensive multi-leg strategy that has a realistic chance of being fully profitable. Cinemark (CNK) For extreme contrarians, Cinemark (CNK) may be an intriguing name for its implied discount. On Friday, CNK stock dropped nearly 4%, while for the trailing week, it hemorrhaged almost 11%. On a year-to-date basis, the security — which is tied to the struggling movie theater business model — is down 16.49%. It's a mess but it has the potential to be meme-able. In the past 10 weeks, the market voted to buy CNK stock four times and sell six times. Throughout this period, CNK incurred a downward trajectory. For brevity, we can label this sequence as 4-6-D. Through past analogs, we can identify that this sequence has materialized 46 times on a rolling basis since January 2019. In 58.7% of cases, the following week's price action results in upside, with a median return of 3.87%. As a baseline, the next-week upside probability is only 51.16%. Therefore, assuming that the implications of the 4-6-D hold up, there's a compelling incentive to place a wager. With CNK stock closing at $25.87, it could swing close to $27 in short order. It's a terribly risky idea but for hardened speculators, the 26/27 bull call spread expiring Aug. 15 could be attractive. Confluent (CFLT) It's no exaggeration to say that Confluent (CFLT) got obliterated this past week. On Friday, CFLT stock dropped 3%, which would be notable in and of itself. However, the real drama occurred the day before. Following a second-quarter earnings print that left investors severely disappointed, CFLT opened sharply lower against Wednesday's close. When the dust settled, the security had lost almost 38% in the trailing five sessions. Generally, it's best to avoid enterprises exhibiting such extreme volatility. However, the market has enticingly printed a relatively rare 6-4-D sequence. It's unusual because, despite the number of accumulative sessions outweighing distributive, the overall trajectory is negative. This quantitative signal has flashed 23 times since the company's public market debut in 2021. Notably, in 65.22% of cases, the following week's price action results in upside, with a median return of 3.79%. As a baseline, the chance that a long position in CFLT stock will rise is only 53.49%. Subsequently, there appears to be a clear incentive to place a wager. With CFLT closing at $17.20 on Friday, it could jump to $17.85, perhaps close to $18, in short order. With that said, the most aggressive idea that you can arguably consider while still being rational is the 17/18 bull spread expiring Aug. 15. On the date of publication, Josh Enomoto did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
